Prodynorphin gene promoter repeat associated with cocaine/alcohol codependence.
- Authors
- Williams, Tanya J; LaForge, K Steven; Gordon, Derek; Bart, Gavin; Kellogg, Scott; Ott, Jurg; Kreek, Mary Jeanne
- Year
- 2007
- Journal
- Addiction biology
- PMID
- 17559549
- DOI
- 10.1111/j.1369-1600.2007.00069.x
There is strong evidence for a genetic contribution to individual differences in vulnerability to drug addictions. Studies have shown that the 68-base pair repeat polymorphism in the promoter region of the human prodynorphin gene contains a putative AP-1 binding site, and that three or four repeat copies result in greater transcriptional activation. Here, we report on a separate cohort of 302 subjects ascertained and characterized extensively by Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition and Addiction Severity Index criteria as: (1) a control group of 127 subjects with no history of alcohol or drug abuse or dependence; (3) a case group of 82 with cocaine dependence only; and (3) a case group of 93 with cocaine and alcohol codependence. The promoter region of the prodynorphin gene containing the repeat was amplified from genomic DNA by polymerase chain reaction and analyzed via gel electrophoresis. Statistical tests were performed with data stratified by the three major ethnic groups studied: African American, Caucasian and Hispanic. For analyses, genotypes were grouped into short (1,1; 1,2; 2,2), short/long (1,3; 2,3; 1,4; 2,4) and long (3,3; 3,4; 4,4) repeats. Deviation from Hardy-Weinberg Equilibrium in the African American control group necessitated testing for association using grouped genotypes rather than grouped alleles. In controls, a significant difference was found in grouped genotype distribution among ethnicities. We found a point-wise, but not experiment-wise across-ethnicities, significant difference in grouped genotype frequency between the cocaine/alcohol-codependent group and the controls in African Americans, with genotypes containing longer alleles found at higher frequency in the codependent group.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Opioid Use Disorders: Prevention, Diagnosis, and Treatment Strategies to Mitigate Addiction Risks. | Agarwal U et al. | β | 2025 | β |
| Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain. | Nosova O et al. | β | 2021 | β |
| Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies. | Guerin AA et al. | β | 2021 | β |
| Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. | Randesi M et al. | β | 2020 | β |
| Association of variants of prodynorphin promoter 68-bp repeats in caucasians with opioid dependence diagnosis: Effect on age trajectory of heroin use. | Yuferov V et al. | β | 2019 | β |
| Current status of opioid addiction treatment and related preclinical research. | Kreek MJ et al. | β | 2019 | β |
| Evaluation of prodynorphin gene polymorphisms and their association with heroin addiction in a sample of the southeast Iranian population. | Hashemi M et al. | β | 2018 | β |
| Gender-specific association of functional <i>prodynorphin</i> 68 bp repeats with cannabis exposure in an African American cohort. | Yuferov V et al. | β | 2018 | β |
| Genetic variation and epigenetic modification of the prodynorphin gene in peripheral blood cells in alcoholism. | D'Addario C et al. | β | 2017 | β |
| A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction. | Bell RL et al. | β | 2016 | β |
| Association between VNTR Polymorphism in Promoter Region of Prodynorphin (PDYN) Gene and Methamphetamine Dependence. | Saify K et al. | β | 2015 | β |
| Clinically relevant genetic biomarkers from the brain in alcoholism with representation on high resolution chromosome ideograms. | Manzardo AM et al. | β | 2015 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| Poststress block of kappa opioid receptors rescues long-term potentiation of inhibitory synapses and prevents reinstatement of cocaine seeking. | Polter AM et al. | β | 2014 | β |
| Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence. | Yan J et al. | β | 2014 | β |
| Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. | Karpyak VM et al. | β | 2013 | β |
| Kappa opioid receptors regulate stress-induced cocaine seeking and synaptic plasticity. | Graziane NM et al. | β | 2013 | β |
| PDYN rs2281285 variant association with drinking to avoid emotional or somatic discomfort. | Preuss UW et al. | β | 2013 | β |
| Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history. | Proudnikov D et al. | β | 2013 | β |
| Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. | Clarke TK et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| ΞΊ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. | Butelman ER et al. | β | 2012 | β |
| Alcohol dependence, disinhibited behavior and variation in the prodynorphin gene. | Flory JD et al. | β | 2011 | β |
| Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity. | Rouault M et al. | β | 2011 | β |
| Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity. | Gieryk A et al. | β | 2010 | β |
| Neurobiology of dysregulated motivational systems in drug addiction. | Edwards S et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | β | 2010 | β |
| A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. | Yuferov V et al. | β | 2009 | β |
| An association of prodynorphin polymorphisms and opioid dependence in females in a Chinese population. | Clarke TK et al. | β | 2009 | β |
| Association of variants in MANEA with cocaine-related behaviors. | Farrer LA et al. | β | 2009 | β |
| Bidirectional translational research: Progress in understanding addictive diseases. | Kreek MJ et al. | β | 2009 | β |
| Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes? | Hansell NK et al. | β | 2009 | β |
| Opiate and cocaine addiction: from bench to clinic and back to the bench. | Kreek MJ et al. | β | 2009 | β |
| A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. | Edenberg HJ et al. | β | 2008 | β |
| Endogenous opiates and behavior: 2007. | Bodnar RJ | β | 2008 | β |
| Role of a functional human gene polymorphism in stress responsivity and addictions. | Kreek MJ | β | 2008 | β |